ArticleBlood2024

Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients.

Eleftheria Kampouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.